PTC Therapeutics | PTCT - Выручка от реализации

Биржевая цена
65.30
Изменение за день
-1.78 -2.65%
Ежемесячно
-7.38%
Ежегодный
14.28%
Q1 прогноз
63.34




Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12